6:2 FTS
6:2 Fluorotelomer Sulfonic Acid
3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctane-1-sulfonic acid
A short-chain fluorotelomer sulfonic acid (6 perfluorinated + 2 alkyl carbons) and the principal PFAS-replacement chemistry in post-2002 AFFF firefighting foams. Detected in 275 U.S. utilities serving ~15 million people under UCMR 5.
Primary concern: Immune and liver toxicity
Affected organ systems
Health effects
Exposure routes
Vulnerable populations
Overview
6:2 Fluorotelomer sulfonic acid (6:2 FTS or 6:2 FTSA; also THPFOS) is a short-chain fluorotelomer sulfonic acid consisting of a perfluorinated six-carbon tail (C6F13) bonded to a two-carbon CH2CH2- spacer terminating in a sulfonic acid head group. After the 3M-led phaseout of PFOS-based aqueous film-forming foam (AFFF) in 2000-2002, 6:2 FTS-based fluorotelomer surfactants became the principal replacement chemistry for firefighting foams marketed as safer alternatives. The compound has since become one of the most environmentally widespread PFAS analytes under UCMR 5, detected in 275 U.S. public water systems serving roughly 15 million people, with highest concentrations clustered in Florida, Texas, and Virginia.
Pollution sources
Sources
6:2 FTS enters drinking water primarily through fluorotelomer-based AFFF use at military airfields, civilian airports, oil refineries, fire-training facilities, and chemical-plant fire suppression systems. Unlike 4:2 FTS (a degradation byproduct), 6:2 FTS is an intentional commercial product as well as an environmental transformation intermediate of polyfluoroalkyl precursors in modern AFFF formulations. Contamination plumes are especially well-documented at Pensacola NAS, Dallas-Fort Worth area airports, Miami-Dade utilities, and Northern Virginia drinking-water systems serving the DC metro. Like other PFAS, 6:2 FTS is highly mobile in groundwater and resists further degradation, migrating with little attenuation from source areas into source-water wells and surface intakes.
Health risks
6:2 FTS was originally marketed as a 'safer' short-chain alternative to PFOS, but emerging toxicology indicates it shares many of the same hazards. Subchronic animal studies (Sheng et al. 2018 and others) have linked 6:2 FTS to hepatotoxicity, thyroid hormone disruption, and altered serum lipid profiles at low ppm exposures. It has not been formally classified as a carcinogen by IARC or NTP, but its environmental persistence, mobility, and structural similarity to PFOS keep it under active regulatory review. Of particular concern is its potential to transform in the environment and human body into shorter-chain perfluoroalkyl carboxylic acids, complicating risk assessment. 6:2 FTS is monitored under UCMR 5 but is not currently subject to a federal MCL.
Effective treatments
Does not remove
NSF certifications
Water treatment
6:2 FTS is removed by granular activated carbon (GAC), anion exchange resin, and high-pressure membranes including reverse osmosis and nanofiltration. Short-chain fluorotelomers like 6:2 FTS tend to break through GAC media earlier than long-chain PFAS such as PFOA and PFOS, so column run times must be shortened or anion exchange resins selective for short-chain PFAS deployed. Conventional treatment processes — coagulation, sand filtration, disinfection, UV, and ozonation — do not remove 6:2 FTS. Boiling concentrates rather than removes it. NSF/ANSI 53 and NSF P473 certify point-of-use filters for PFAS reduction; NSF/ANSI 58 covers RO systems.
Gallery

Chemistry + classification data sourced from public databases (PubChem, EPA CompTox, IARC monographs); 3D molecular models from 3d.nih.gov where available.